CureVac (NASDAQ:CVAC) just reported results for the first quarter of 2024.
- CureVac reported earnings per share of -33 cents. This was below the analyst estimate for EPS of -26 cents.
- The company reported revenue of $13.36 million.
- This was 3.79% worse than the analyst estimate for revenue of $13.89 million.